<DOC>
	<DOCNO>NCT02995512</DOCNO>
	<brief_summary>The aim study determine immuno-modulatory mechanistic effect colchicine patient myocardial infarction ( MI ) . Investigators hypothesize colchicine exerts anti-inflammatory property switch metabolism neutrophil , thereby reduce expression adhesion molecules responsible recruitment MI .</brief_summary>
	<brief_title>Mechanistic Effects Colchicine Patients With Myocardial Infarction</brief_title>
	<detailed_description>This pilot study explore mechanistic effect colchicine patient MI . The study conduct sequentially 3 part : 1 . Blood collect 10 healthy volunteer protocol development . ( Group 1 ) . 2 . Blood collect 20 MI patient within 24 hour presentation New York University ( NYU ) Langone Medical Center Bellevue Hospital Center ( BHC ) . Neutrophil adhesion human aortic endothelial cell , quantitative expression adhesion molecule surface neutrophil , quantitative level adhesion molecule neutrophils endothelial cell , neutrophil metabolism , use Seahorse Analyzer evaluate pre- post-addition vitro colchicine . ( Group 2 ) 3 . The standard low-dose load regimen colchicine ( 1.2 mg follow 0.6 mg one hour later ) administer 20 patient MI BHC . Blood collect prior drug administration , 2 3 hour completion colchicine load , 23 24 hour completion colchicine load . Neutrophil adhesion human aortic endothelial cell , quantitative expression adhesion molecule surface neutrophil , quantitative level adhesion molecule neutrophils endothelial cell , neutrophil metabolism evaluate pre- post-addition vitro colchicine ( exact marker determine base result viro study ) . ( Group 3 )</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>18 year age healthy volunteer subset . 18 year age within 24 hour MI MI subset . Subjects 3 group exclude meet one follow criterion history myelodysplasia ; Use antiinflammatory medication , exception aspirin , within 5 halflives ; medication know interact colchicine ; know creatinine clearance &lt; 30 cc/minute ( severe kidney disease ) ; pregnant ; Unable consent . MI subject oral colchicine administer follow additional exclusion criterion : history intolerance colchicine ; acute chronic symptom diarrhea within 72 hour prior enrollment ; hemoglobin &lt; 10 g/dL clinical evidence active bleeding study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>colchicine</keyword>
	<keyword>anti-inflammatory</keyword>
</DOC>